These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28541457)

  • 21. Evaluation of in vitro and in vivo activity of benzindazole-4,9-quinones against Cryptosporidium parvum.
    Kayser O; Waters WR; Woods KM; Upton SJ; Keithly JS; Laatsch H; Kiderlen AF
    J Antimicrob Chemother; 2002 Dec; 50(6):975-80. PubMed ID: 12461020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases.
    Van Voorhis WC; Hulverson MA; Choi R; Huang W; Arnold SLM; Schaefer DA; Betzer DP; Vidadala RSR; Lee S; Whitman GR; Barrett LK; Maly DJ; Riggs MW; Fan E; Kennedy TJ; Tzipori S; Doggett JS; Winzer P; Anghel N; Imhof D; Müller J; Hemphill A; Ferre I; Sanchez-Sanchez R; Ortega-Mora LM; Ojo KK
    Vet Parasitol; 2021 Jan; 289():109336. PubMed ID: 33418437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of mangiferin against Cryptosporidium parvum in a neonatal mouse model.
    Perrucci S; Fichi G; Buggiani C; Rossi G; Flamini G
    Parasitol Res; 2006 Jul; 99(2):184-8. PubMed ID: 16547730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of selenium on Cryptosporidium parvum infection in vitro and in vivo.
    Huang K; Yang S
    Biol Trace Elem Res; 2002; 90(1-3):261-72. PubMed ID: 12666840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy.
    Ojo KK; Dangoudoubiyam S; Verma SK; Scheele S; DeRocher AE; Yeargan M; Choi R; Smith TR; Rivas KL; Hulverson MA; Barrett LK; Fan E; Maly DJ; Parsons M; Dubey JP; Howe DK; Van Voorhis WC
    Int J Parasitol; 2016 Dec; 46(13-14):871-880. PubMed ID: 27729271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New potential therapies for cryptosporidiosis: an analysis of variables affecting drug efficacy.
    Rehg J
    Folia Parasitol (Praha); 1994; 41(1):23-6. PubMed ID: 8050751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bobel-24 activity against Cryptosporidium parvum in cell culture and in a SCID mouse model.
    Rueda C; Fenoy S; Simón F; Del Aguila C
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1150-2. PubMed ID: 18160525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral dosing of neonatal mice with sucrose reduces infection with Cryptosporidium parvum.
    Harp JA
    J Parasitol; 1999 Oct; 85(5):952-5. PubMed ID: 10577733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites.
    Jiménez-Meléndez A; Ojo KK; Wallace AM; Smith TR; Hemphill A; Balmer V; Regidor-Cerrillo J; Ortega-Mora LM; Hehl AB; Fan E; Maly DJ; Van Voorhis WC; Álvarez-García G
    Int J Parasitol; 2017 Oct; 47(12):811-821. PubMed ID: 28899692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dicationic furans inhibit development of Cryptosporidium parvum in HSD/ICR suckling Swiss mice.
    Blagburn BL; Drain KL; Land TM; Moore PH; Kinard RG; Lindsay DS; Kumar A; Shi J; Boykin DW; Tidwell RR
    J Parasitol; 1998 Aug; 84(4):851-6. PubMed ID: 9714224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of ivermectin on Cryptosporidium parvum in experimentally infected rat.
    Zinada NY
    J Egypt Soc Parasitol; 2000 Dec; 30(3):747-52. PubMed ID: 11198372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.
    Robinson P; Martin P; Garza A; D'Souza M; Mastrangelo MA; Tweardy D
    J Parasitol; 2008 Oct; 94(5):1150-4. PubMed ID: 18576802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An immunosuppressed rat model for evaluation of anti-Cryptosporidium activity of sinefungin.
    Brasseur P; Favennec L; Leméteil D; Roussel F; Ballet JJ
    Folia Parasitol (Praha); 1994; 41(1):13-6. PubMed ID: 8050749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with agmatine inhibits Cryptosporidium parvum infection in infant mice.
    Moore D; Waters WR; Wannemuehler MJ; Harp JA
    J Parasitol; 2001 Feb; 87(1):211-3. PubMed ID: 11227893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice.
    Barrier M; Lacroix-Lamandé S; Mancassola R; Auray G; Bernardet N; Chaussé AM; Uematsu S; Akira S; Laurent F
    J Infect Dis; 2006 May; 193(10):1400-7. PubMed ID: 16619188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Tools for Cryptosporidium Lead to New Hope for Cryptosporidiosis.
    Ward HD
    Trends Parasitol; 2017 Sep; 33(9):662-664. PubMed ID: 28750950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The loading of labelled antibody-engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum.
    Bondioli L; Ludovisi A; Tosi G; Ruozi B; Forni F; Pozio E; Vandelli MA; Gómez-Morales MA
    Parasitology; 2011 Sep; 138(11):1384-91. PubMed ID: 21819637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of benzimidazoles against cryptosporidiosis in neonatal BALB/c mice.
    Fayer R; Fetterer R
    J Parasitol; 1995 Oct; 81(5):794-5. PubMed ID: 7472880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bridging the gap between preclinical and clinical studies using pharmacokinetic-pharmacodynamic modeling: an analysis of GDC-0973, a MEK inhibitor.
    Wong H; Vernillet L; Peterson A; Ware JA; Lee L; Martini JF; Yu P; Li C; Del Rosario G; Choo EF; Hoeflich KP; Shi Y; Aftab BT; Aoyama R; Lam ST; Belvin M; Prescott J
    Clin Cancer Res; 2012 Jun; 18(11):3090-9. PubMed ID: 22496205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.